IGFBP3 and malignant colon neoplasm: The weight of evidence surely implicates this gene as a prominent driver of CRC cancer aggressiveness despite its being at odds with older studies connecting IGFBP3 expression to an anti-proliferative effect on the growth of colon cancer cells (reviewed in [24]).